Q61453 AF NFT

Interleukin-17A

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicb35pdjxuve4dog2c2wot77b4metionmbjyljej4pamt7nkmr3em/metadata.json
IPFS of structure file: 
bafybeigxhtfiee42kxmyhwpk2opyqbm5qkeoy4y6scnxfc6cqrsenwypiy/AF-Q61453-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xA89f05e8B410d903A7A962FDDa2fC551E1DB84C9
First NFT owner address (bech32): 
genesis14z0st695zrvs8fafvt7a5t7928sahpxfv2e79u
Current NFT ID #187739 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
187739
Accession (UniProt):
Q61453
Name::
Interleukin-17A
Experimental Method:
Predicted structure
Sequence source:
RATTUS NORVEGICUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q61453 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q61453|IL17_RAT Interleukin-17A OS=Rattus norvegicus OX=10116 GN=Il17a PE=2 SV=1 MCLMLLLLLNLEATVKAAVLIPQSSVCPNAEANNFLQNVKVNLKVINSLSSKASSRRPSDYLNRSTSPWTLSRNEDPDRYPSVIWEAQCRHQRCVNAEGKLDHHMNSVLIQQEILVLKREPEKCPFTFRVEKMLVGVGCTCVSSIVRHAS